博文
癌症疫苗mRNA-4157（V940）
||
mRNA癌症疫苗与PD-1联合免疫治疗有助于提高疗效
https://blog.sciencenet.cn/blog-3302154-1440162.html
http://www.pubmedplus.cn/P/SearchQuickResult?wd=20cffa69-87b3-474c-9cb0-67d631e0079f
| 01. | Humans | 2 篇 | 66.667% |
| 02. | Melanoma | 2 篇 | 66.667% |
| 03. | Adjuvants, Immunologic | 1 篇 | 33.333% |
| 04. | Antibodies, Monoclonal, Humanized | 1 篇 | 33.333% |
| 05. | Antineoplastic Combined Chemotherapy Protocols | 1 篇 | 33.333% |
| 06. | Immune Checkpoint Inhibitors | 1 篇 | 33.333% |
| 07. | Skin Neoplasms | 1 篇 | 33.333% |
| 08. | Vaccines, Synthetic | 1 篇 | 33.333% |
| 09. | mRNA Vaccines | 1 篇 | 33.333% |
https://blog.sciencenet.cn/blog-280034-1442946.html
上一篇：癌症疫苗Tecemotide
下一篇：放疗和免疫治疗
扫一扫，分享此博文